Article
A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin.
Cancer research - 15 Feb 2000
Zhang Z, Liu Q, Lantry L E, Wang Y, Kelloff G J, Anderson M W, Wiseman R W, Lubet R A, You M
Abstract excerpt
Recent evidence indicates that individuals with a p53 germ-line mutation (Li-Fraumeni syndrome) have a 50% risk of developing lung cancer by age 60. In this study, p53 heterozygous knockout mice and p53 transgenic mice carrying a dominant negative mutant were crossed with the A/J mouse, which is highly susceptible to lung tumor induction, to investigate whether a p53 germ-line mutation is a predisposing gene for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.